Effects of angiotensin-II receptor blockers on experimental autoimmune myocarditis

International Journal of Cardiology

Volumn 137, Issue 3, 2009, Pages 282-288

  Liu, Xuefei ^a   Zhu, Xinglei ^a   Wang, Aiying ^a   Fan, Hui ^a   Yuan, Haitao ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Angiotensin II receptor blockers; Myocarditis; Myosin; Th balance

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CARDIAC MYOSIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; CORONARY HEMODYNAMICS; DISEASE SEVERITY; DOWN REGULATION; DRUG EFFECT; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL AUTOIMMUNE MYOCARDITIS; HEART FAILURE; HEART FUNCTION; HEART MUSCLE INJURY; HISTOPATHOLOGY; IMMUNOMODULATION; LEWIS RAT; LYMPHOCYTE PROLIFERATION; MALE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; RAT; TH1 CELL; TH2 CELL; UPREGULATION;

ANALYSIS OF VARIANCE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; AUTOIMMUNE DISEASES; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; MALE; MYOCARDITIS; RATS; RATS, INBRED LEW; TETRAZOLES; TH1 CELLS; TH2 CELLS; VALINE;

EID: 70749111952     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.09.540     Document Type: Article

References (46)

1. Mason J.W., O'Connell J.B., Herskowitz A., et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 333 (1995) 269-275
2. D'Ambrosio A., Patti G., Manzoli A., et al. The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 85 (2001) 499-504
3. Maisch B., Richter A., Sandmoller A., Portig I., and Pankuweit S. BMBF-heart failure network. Inflammatory Dilated Cardiomyopathy (DCMI). Herz 30 (2005) 535-544
4. Drory Y., Turetz Y., Hiss Y., et al. Sudden unexpected death in persons less than 40 years of age. Am J Cardiol 68 (1991) 1388-1392
5. Hiramitsu S., Morimoto S., Kato S., et al. Clinical course of myocarditis through the acute, fulminant and fatal chronic stages. An autopsy case. Circ J 70 (2006) 1086-1090
6. Mason J.W. Myocarditis and dilated cardiomyopathy: an inflammatory link. Cardiovasc Res 60 (2003) 5-10
7. Mehra V.C., Ramgolam V.S., and Bender J.R. Cytokines and cardiovascular disease. J Leukoc Biol 78 (2005) 805-818
8. Shioi T., Matsumori A., and Sasayama S. Persistent expression of cytokines in the chronic stage of viral myocarditis in mice. Circulation 94 (1996) 2930-2937
9. Yuan Z.Y., Liu Y., Liu Y., et al. PPAR-gamma ligands inhibit the expression of inflammatory cytokines and attenuate autoimmune myocarditis. Chin Med J (Engl) 117 (2004) 1253-1255
10. Liu H.W., Iwai M., Takeda-Matsubara Y., et al. Effect of estrogen and AT1 receptor blocker on neointima formation. Hypertension 40 (2002) 451-457
11. Suda O., Tsutsui M., Morishita T., et al. Asymmetric dimethylarginine causes arteriosclerotic lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress. Arterioscler Thromb Vasc Biol 24 (2004) 1682-1688
12. Navalkar S., Parthasarathy S., Santanam N., and Khan B.V. Irbesartan, an angiotensin type 1 receptor inhibitor, regulates makers of inflammation in patients with premature atherosclerosis. J Am. Coll. Cardiol 37 (2001) 440-444
13. Koh K.K., Ahn J.Y., Han S.H., et al. Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients. J Am Col Cardiol 42 (2003) 905-910
14. Fliser D., Buchholz K., and Haller H. Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation. Circulation 110 (2004) 1103-1107
15. Burnier M. Angiotensin II type 1 receptor blockers. Circulation 103 (2001) 904-912
16. Mollnau H., Wendt M., Szöcs K., et al. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90 (2002) E58-65
17. Warnholtz A., Nickering G., Schultz E., et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation 99 (1999) 2027-2033
18. Diez J., Querejeta R., Lopez B., Gonzalez A., Larman M., and Martinez Ubago J.L. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 105 (2002) 2512-2517
19. Krämer C., Sunkomat J., Witte J., et al. Angiotensin II receptor-independent antiinflammatory and antiaggregatory properties of losartan: role of the active metabolite EXP 3179. Circ Res 90 (2002) 770-776
20. Weinstock J.V., Blum A.M., and Kassab J.T. Angiotensin II is chemotactic, for a T-cell subset which can express migration factor activity in murine schistosomiasis mansoni. Cell Immunol 107 (1987) 180-187
21. 1 antagonist, suppresses cytotoxic myocardial injury in autoimmune heart failure. Am J Physiol Heart Circ Physiol 289 (2005) H1147-1152
22. Shioji K., Kishimoto C., Nakamura H., et al. Overexpression of thioredoxin-1 in transgenic mice attenuates adriamycin-induced cardiotoxicity. Circulation 106 (2002) 1403-1409
23. Shioji K., Kishimoto C., and Sasayama S. Fc receptor-mediated inhibitory effect of immunoglobulin therapy on autoimmune giant cell myocarditis: concomitant suppression of the expression of dendritic cells. Circ Res 89 (2001) 540-546
24. Yuan Z., Kishimoto C., and Shioji K. Beneficial effects of low dose benidipine in acute autoimmune myocarditis. Suppressive effects on inflammatory cytokines and inducible nitric oxide synthase. Circulation 67 (2003) 545-550
25. Yuan Z., Shioji K., Kihara Y., Takenaka H., Onozawa Y., and Kishimoto C. Cardioprotective effects of carvedilol on acute autoimmune myocarditis. Anti-inflammatory effects associated with antioxidant property. Am J Physiol Heart Circ Physiol 286 (2004) H83-90
26. Zierhut W., Studer R., Laurent D., et al. Left ventricular wall stress and sarcoplasmic reticulum Ca(2+)-ATPase gene expression in renal hypertensive rats: dose-dependent effects of ACE inhibition and AT1-receptor blockade. Cardiovasc Res 31 (1996) 758-768
27. Yagi S., Morita T., and Katayama S. Combined treatment with an AT1 receptor blocker and angiotensin converting enzyme inhibitor has an additive effect on inhibiting neointima formation via improvement of nitric oxide production and suppression of oxidative stress. Hypertens Res 27 (2004) 129-135
28. Shioi T., Kang P.M., Douglas P.S., et al. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J 19 (2000) 2537-2548
29. Matsui S., Zong Z.P., Han J.F., Katsuda S., Yamaguchi N., and Fu M.L. Amiodarone minimizes experimental autoimmune myocarditis in rats. Eur J Pharmacol 469 (2003) 165-173
30. Okura Y., Takeda K., Honda S., et al. Recombinant murine interleukin-12 facilitates induction of cardiac myosin specific type 1 helper T cells in rats. Circ Res 82 (1998) 1035-1042
31. Leon J.S., Wang K., and Engman D.M. Captopril ameliorates myocarditis in acute experimental Chagas disease. Circulation 107 (2003) 2264-2269
32. Liu W., Li W.M., Gao C., and Sun N.L. Effects of atorvastatin on the Th1/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats. Journal of Autoimmunity 25 (2005) 258-263
33. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76 (1994) 301-314
34. Bergelson J.M., Cunningham J.A., Droguett G., et al. Isolation of common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275 (1997) 1320-1323
35. Li Y., Heuser J.S., Kosanke S.D., Hemric M., and Cunningham M.W. Cryptic epitope identified in rat and human cardiac myosin S2 region induces myocarditis in the Lewis rat. J Immunol 172 (2004) 3225-3234
36. The GISEN Group. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349 (1997) 1857-1863
37. Stigant CE., Cohen J., Vivera M., and Zaltzman J.S. ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy. Am. J. Kidney Dis 35 (2000) 58-63
38. Amuchastegui S.C., Azzollini N., Mister M., Pezzotta A., Perico N., and Remuzzi G. Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism. J Am Soc Nephrol 9 (1998) 1948-1955
39. Hisada Y., Sugaya T., Yamanouchi M., et al. Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J Clin Invest 103 (1999) 627-635
40. Benediktsson H., Chea R., Davidoff A., and Paul L.C. Antihypertensive drug treatment in chronic renal allograft rejection in the rat: effect on structure and function. Transplantation 62 (1996) 1634-1642
41. Nataraj C., Oliverio M.I., Mannon R.B., et al. Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway. J Clin Invest 104 (1999) 1693-1701
42. Suzuki Y., Gomez-Guerrero C., Shirato I., et al. Susceptibility to T cell-mediated injury in immune complex disease is linked to local activation of renin-angiotensin system: the role of NF-AT pathway. J Immunol 169 (2002) 4136-4146
43. Yamamoto K., Shioi T., Uchiyama K., Miyamoto T., Sasayama S., and Matsumori A. Attenuation of virus-induced myocardial injury by inhibition of the angiotensin II type 1 receptor signal and decreased nuclear factor-kappa B activation in knockout mice. J Am Coll Cardio 42 (2003) 2000-2006
44. Rezkalla S., Kloner R.A., Khatib G., and Khatib R. Beneficial effects of captopril in acute coxsackievirus B3 murine myocarditis. Circulation 81 (1990) 1039-1046
45. Yoshinori S.E.K.O. Effect of the angiotensin II receptor blocker olmesartan on the development of murine acute myocarditis caused by coxsackievirus B3. Clin Sci 110 (2006) 379-386
46. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150